449 related articles for article (PubMed ID: 24444396)
1. Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors.
Jaleta GN; Gudina EK; Getinet W
BMC Res Notes; 2014 Jan; 7():45. PubMed ID: 24444396
[TBL] [Abstract][Full Text] [Related]
2. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
[TBL] [Abstract][Full Text] [Related]
3. Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study.
De Jong KA; Czeczor JK; Sithara S; McEwen K; Lopaschuk GD; Appelbe A; Cukier K; Kotowicz M; McGee SL
Cardiovasc Diabetol; 2017 Feb; 16(1):21. PubMed ID: 28178970
[TBL] [Abstract][Full Text] [Related]
4. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal change in left ventricular hypertrophy in the elderly on antihypertensive therapy.
Ahmad A; Nawaz HM; Nevins L; Nawaz H
Conn Med; 2003 Feb; 67(2):67-73. PubMed ID: 12664833
[TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda.
Nabbaale J; Kibirige D; Ssekasanvu E; Sebatta ES; Kayima J; Lwabi P; Kalyesubula R
BMC Res Notes; 2015 May; 8():198. PubMed ID: 25971452
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
9. Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.
Zhang K; Huang F; Chen J; Cai Q; Wang T; Zou R; Zuo Z; Wang J; Huang H
Medicine (Baltimore); 2014 Nov; 93(25):e130. PubMed ID: 25437025
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
12. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
13. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
[TBL] [Abstract][Full Text] [Related]
14. Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).
Ruggenenti P; Iliev I; Costa GM; Parvanova A; Perna A; Giuliano GA; Motterlini N; Ene-Iordache B; Remuzzi G;
Diabetes Care; 2008 Aug; 31(8):1629-34. PubMed ID: 18443191
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Clinical Correlates of Left Ventricular Hypertrophy in Black Africans.
Baldo MP; Gonçalves MA; Capingana DP; Magalhães P; da Silva ABT; Mill JG
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):283-289. PubMed ID: 29956112
[TBL] [Abstract][Full Text] [Related]
16. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
[TBL] [Abstract][Full Text] [Related]
17. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure control and left ventricular hypertrophy in hypertensive Nigerians.
Salako BL; Ogah OS; Adebiyi AA; Oladapo OO; Aje A; Adebayo AK; Ojji DB; Ipadeola A; Nwafor CE
Ann Afr Med; 2009; 8(3):156-62. PubMed ID: 19884691
[TBL] [Abstract][Full Text] [Related]
19. Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.
Morisco C; Argenziano L; Tozzi N; Mele AF; Ricciardelli B; Condorelli G; Trimarco B
Drugs; 1993; 46 Suppl 2():88-94. PubMed ID: 7512489
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
